NeuroScientific Biopharmaceuticals (ASX:NSB) Share Price and News

NeuroScientific Biopharmaceuticals Limited engages in the research and development of novel peptide-based pharmaceutical products. The company is involved in the development of therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies. Its lead drug candidates include EmtinB for treatment of neurodegenerative Alzheimer's disease, multiple scierosis, glaucoma, optic nerve atrophy, and other diseases. The company was incorporated in 2002 and is based in Cottesloe, Australia.

Expand Company Description

Market Cap (9-Oct) $5,639,595 (1,259th)	Close (30-Jun) $0.080 0 (0%)	Volume (30-Jun) 244,049	Shortsold (6-Dec) 2,660 (0.00%) (615th)
52w High $0.078	52w Low $0.033	P/E -	EPS 0

	Subject
	NSB NSB Ann: Change of Director's Interest Notice - Rennie
	1 (current) 2 3
	NSB NSB Ann: Change of Director's Interest Notice - Uvarov
	NSB NSB Ann: Change of Director's Interest Notice - Rennie
	NSB NSB Ann: Change of Director's Interest Notice - Uvarov
	NSB NSB Ann: Change of Director's Interest Notice - Rennie
	NSB NSB Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	NSB NSB Ann: Positive treatment effect in MS animal study
	NSB NSB Ann: Half Yearly Report and Accounts
	NSB NSB Ann: Notification of cessation of securities - NSB
	NSB NSB Ann: Investor Update Presentation
	NSB NSB Ann: Investor Update Webinar
	NSB NSB Ann: R&D Tax Incentive Refund Received
	NSB NSB Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	NSB NSB Ann: Patent Application - Updated Announcement
	NSB NSB Ann: NSB files new patent
	NSB NSB Ann: Results of Meeting
	NSB NSB Ann: Chair's address to shareholders & AGM presentation
	NSB NSB Ann: Appointment of Interim CEO
	NSB NSB Ann: Executive Management Changes
	NSB NSB Ann: NSB receives R&D Advance & Overseas Finding
	NSB NSB Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	NSB NSB Ann: Notice of Annual General Meeting
	NSB NSB Ann: Investor Update Presentation
	NSB NSB Ann: Investor Update Webinar
	NSB NSB Ann: Final Director's Interest Notice - Liddelow
	NSB NSB Ann: CEO Resignation
	NSB NSB Ann: Investor Update Webinar
	NSB NSB Ann: HREC decision to not approve Phase I Clinical Trial
	NSB NSB Ann: Corporate Governance Statement
	NSB NSB Ann: Appendix 4G
	NSB NSB Ann: NeuroScientific releases FY2022 Results
	NSB NSB Ann: 2022 Annual Report and Appendix 4E
	NSB NSB Ann: R&D Tax Incentive Refund Received
	NSB NSB Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	NSB NSB Ann: HREC Submission for Phase I Clinical Trial
	NSB NSB Ann: First Subject Recruited for Early-Phase Clinical Trial
	NSB NSB Ann: Notification of cessation of securities - NSB
	NSB NSB Ann: Company Presentation - Gold Coast Investment Showcase
	NSB NSB Ann: Clarification of Results in MS Animal Study
	NSB NSB Ann: Notification regarding unquoted securities - NSB
	NSB NSB Ann: Issue of Employee Options
	NSB NSB Ann: Positive results in MS animal study
	NSB NSB Ann: Ethics Approval Granted for Early-Phase Clinical Trial
	NSB NSB Ann: HREC Submission for early-phase Clinical Trial
	NSB NSB Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	NSB NSB Ann: Positive safety result supports advance to clinical trials
	NSB NSB Ann: NSB Enhances Management Team
	NSB NSB Ann: Company Presentation
	NSB NSB Ann: NSB presenting at Broker Briefing Investor Webinar
	NSB NSB Ann: New data demonstrates EmtinB activity in autoimmune diseases

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
09-Oct	$0.04	333,705	+0.00 (8.33%)
08-Oct	$0.04	185,055	0.00 (5.26%)
07-Oct	$0.04	113,163	0.00 (0.00%)
04-Oct	$0.04	298,077	0.00 (0.00%)
03-Oct	$0.04	392,234	+0.00 (5.56%)
02-Oct	$0.04	292,594	0.00 (4.00%)
01-Oct	$0.04	1,896,770	+0.00 (7.14%)
30-Sep	$0.04	144,279	0.00 (7.89%)
11-Sep	$0.04	1,415,720	+0.00 (2.70%)
10-Sep	$0.04	199,708	0.00 (2.63%)
09-Sep	$0.04	30,571	0.00 (2.56%)
06-Sep	$0.04	76	0.00 (0.00%)
05-Sep	$0.04	0	0.00 (0.00%)
04-Sep	$0.04	55,000	0.00 (0.00%)
03-Sep	$0.04	65,000	0.00 (0.00%)
4 up, 5 down, and 6 flat days

High $0.08	Low $0.08	Trades 10	Turnover $19,245	Volume 244,049
30 June 2023 at 1:52pm

High $0.08	Low $0.08	Trades 10	Turnover $19,245	Volume 244,049
30 June 2023 at 1:52pm

NeuroScientific Biopharmaceuticals Health Care

$0.080 0.005 (6.67%)

$0.080 0.005 (6.67%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices